BACKGROUND: The soluble form of the haptoglobin-hemoglobin (Hp-Hb) scavenger receptor (sCD163) is a specific plasma/serum marker for macrophage activity. Here, we have characterized molecular forms in serum and investigated a role of sCD163 as a binder of Hp-Hb complexes. METHODS: The sCD163 species in serum (from 50 healthy subjects and 29 patients) were measured with domain-specific ELISAs, purified from serum (from 6 individuals) by affinity chromatography and identified by western blotting and MALDI-TOF/TOF mass spectrometry. Binding to Hp-Hb complexes was investigated by gel-chromatography, surface plasmon resonance (SPR) analyses, and inhibition of Hp-Hb endocytosis in CD163-transfected Chinese hamster ovary (CHO) cells. RESULTS: By using C- and N-terminal-specific ELISAs, no sCD163 concentration differences in plasma were seen, thus indicating a homogenous sCD163 species. Affinity-purified sCD163 from serum migrated as a single band of 130kDa, and spanned at least 945 amino acids (94%) of the total extra-cellular part of CD163. In solution sCD163 only weakly competed for Hp-Hb uptake in CD163-expressing cells, and Hp-Hb saturation of sCD163 in serum was only seen with large excess of Hp-Hb complexes. However, upon immobilisation, recombinant sCD163 bound Hp-Hb with high affinity. This suggests that Hp-Hb is less dissociable when bound to the membrane form of CD163, presumably because of the di- or multivalent nature of Hp-Hp complexes in terms of CD163 binding. CONCLUSIONS: Serum sCD163 is a homogenous protein covering more than 94% of the CD163 ectodomain including the Hp-Hb-binding region. However, CD163 is a poor competitor of Hp-Hb uptake, probably because of its soluble nature, where Hp-Hb cannot take advantage of receptor cross-linkage. Copyright 2009 Elsevier GmbH. All rights reserved.
BACKGROUND: The soluble form of the haptoglobin-hemoglobin (Hp-Hb) scavenger receptor (sCD163) is a specific plasma/serum marker for macrophage activity. Here, we have characterized molecular forms in serum and investigated a role of sCD163 as a binder of Hp-Hb complexes. METHODS: The sCD163 species in serum (from 50 healthy subjects and 29 patients) were measured with domain-specific ELISAs, purified from serum (from 6 individuals) by affinity chromatography and identified by western blotting and MALDI-TOF/TOF mass spectrometry. Binding to Hp-Hb complexes was investigated by gel-chromatography, surface plasmon resonance (SPR) analyses, and inhibition of Hp-Hb endocytosis in CD163-transfected Chinese hamster ovary (CHO) cells. RESULTS: By using C- and N-terminal-specific ELISAs, no sCD163 concentration differences in plasma were seen, thus indicating a homogenous sCD163 species. Affinity-purified sCD163 from serum migrated as a single band of 130kDa, and spanned at least 945 amino acids (94%) of the total extra-cellular part of CD163. In solution sCD163 only weakly competed for Hp-Hb uptake in CD163-expressing cells, and Hp-Hb saturation of sCD163 in serum was only seen with large excess of Hp-Hb complexes. However, upon immobilisation, recombinant sCD163 bound Hp-Hb with high affinity. This suggests that Hp-Hb is less dissociable when bound to the membrane form of CD163, presumably because of the di- or multivalent nature of Hp-Hp complexes in terms of CD163 binding. CONCLUSIONS: Serum sCD163 is a homogenous protein covering more than 94% of the CD163 ectodomain including the Hp-Hb-binding region. However, CD163 is a poor competitor of Hp-Hb uptake, probably because of its soluble nature, where Hp-Hb cannot take advantage of receptor cross-linkage. Copyright 2009 Elsevier GmbH. All rights reserved.
Authors: Hengdao Liu; Dan Lin; Hong Xiang; Wei Chen; Shaoli Zhao; Hui Peng; Jie Yang; Pan Chen; Shuhua Chen; Hongwei Lu Journal: Exp Ther Med Date: 2017-06-14 Impact factor: 2.447
Authors: Juan M Mejia-Vilet; Xiaolan L Zhang; Cristino Cruz; Mayra L Cano-Verduzco; John P Shapiro; Haikady N Nagaraja; Luis E Morales-Buenrostro; Brad H Rovin Journal: J Am Soc Nephrol Date: 2020-04-16 Impact factor: 10.121
Authors: M Nusrat Sharif; Gabriela Campanholle; Eva E Nagiec; Ju Wang; Jameel Syed; Shawn P O'Neil; Yutian Zhan; Karrie Brenneman; Bruce Homer; Hendrik Neubert; Riyez Karim; Nick Pullen; Steven M Evans; Margaret Fleming; Priya Chockalingam; Lih-Ling Lin Journal: PLoS One Date: 2016-05-12 Impact factor: 3.240
Authors: Vincent P O'Reilly; Limy Wong; Claire Kennedy; Louise A Elliot; Shane O'Meachair; Alice Marie Coughlan; Eoin C O'Brien; Michelle M Ryan; Diego Sandoval; Emma Connolly; Gerjan J Dekkema; Jiaying Lau; Wayel H Abdulahad; Jan-Stephan F Sanders; Peter Heeringa; Colm Buckley; Cathal O'Brien; Stephen Finn; Clemens D Cohen; Maja T Lindemeyer; Fionnuala B Hickey; Paul V O'Hara; Conleth Feighery; Sarah M Moran; George Mellotte; Michael R Clarkson; Anthony J Dorman; Patrick T Murray; Mark A Little Journal: J Am Soc Nephrol Date: 2016-03-03 Impact factor: 10.121